title: Response to: 'Biologic discontinuation studies: a systematic review of methods' by van der Maas et al.
authors.affiliation: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, , Boston, Massachusetts, USA.
authors.forename: Kazuki
authors.initials: K
authors.lastname: Yoshida
authors.forename: Yoon-Kyoung
authors.initials: YK
authors.lastname: Sung
authors.forename: Arthur
authors.initials: A
authors.lastname: Kavanaugh
authors.forename: Sang-Cheol
authors.initials: SC
authors.lastname: Bae
authors.forename: Michael E
authors.initials: ME
authors.lastname: Weinblatt
authors.forename: Mitsumasa
authors.initials: M
authors.lastname: Kishimoto
authors.forename: Kazuo
authors.initials: K
authors.lastname: Matsui
authors.forename: Shigeto
authors.initials: S
authors.lastname: Tohma
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Solomon
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001688:Biological Products / Q000008:administration & dosage*; D006801:Humans; D028761:Withholding Treatment
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products
keywords: Adult Onset Still's Disease; Amyloidosis; Analgesics